HOME >> MEDICINE >> NEWS
Britain should adopt universal hepatitis B immunisation

Britain should adopt universal hepatitis B immunisation, says a senior doctor in this week's BMJ.

The United Kingdom is one of the few developed countries that have not implemented universal immunisation. Because the burden of hepatitis B was low and individual rights were considered paramount, a policy of selective immunisation of high-risk groups, such as health care workers, homosexual men, and drug addicts, has been followed.

However, this approach has failed to provide adequate coverage in Britain and should be replaced by universal immunisation, writes Nicholas Beeching of the Royal Liverpool University Hospital.

The hepatitis B virus causes up to a million deaths worldwide every year. In the United Kingdom, 4,500 acute hepatitis B virus infections, 7,500 new cases of chronic infection, and up to 430 cases of hepatitis B related liver cancer are thought to occur, with estimated NHS costs of up to 375m.

The availability of effective and safe vaccines makes primary prevention of hepatitis B an attractive strategy. Universal immunisation has been adopted by over 150 countries, with evidence of effectiveness lasting more than 10 years in preventing infection, carriage, and liver cancer.

In light of this evidence, it is time that Britain's policy was reviewed, he concludes.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
4-Nov-2004


Page: 1

Related medicine news :

1. Sexual lifestyles vary among ethnic groups in Britain
2. Job satisfaction? Not much for Britains hard slog robot workers
3. Study reveals serious north-south health gap in modern Britain
4. Britain not doing enough to stop people from smoking claim public health experts
5. Why Britains gay, lesbian and bisexual Muslims need dedicated support groups
6. Tufts University hosts Britains Royal Geographic Society
7. HIV testing should be routine part of primary health care for sexually active
8. Opponents of needle-exchange programs should think about their message to drug users
9. Public policy should address the social factors behind ill health
10. Ethical discussion should come before research
11. Age shouldnt be a factor in kidney transplantation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Britain should adopt universal hepatitis immunisation

(Date:8/4/2015)... ... 04, 2015 , ... Nathan’s Famous was recently featured on NewsWatch ... large businesses making an impact in their industry. Andrew Tropeano, the host of NewsWatch ... hot dog maker now offers a 50% Reduced Fat All-Beef Frank variety and ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... Winscribe Text results have been impressive so far". , Mr Cauchois attributes ... from Winscribe's French sales partner Dicma and the healthcare technology offered by Winscribe's ...
(Date:8/3/2015)... ... August 04, 2015 , ... While the pace of the economic recovery since the ... clearly been on a growth trajectory for the last six years. Unemployment has dropped from ... trending at a 3.5 percent growth rate in 2014, the U.S. stock market is at ...
(Date:8/3/2015)... ... 03, 2015 , ... Zeiter’s Septic now performs septic installations ... and operated business, Zeiter’s Septic has been serving the community for over 20 ... because of their continued training and perseverance to provide their customers with new ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Code ... the T500 cable , a Bluetooth Code Reader accessory that enables a wireless ... products. The T500 helps enable a variety of barcode reading applications with iPads, ...
Breaking Medicine News(10 mins):Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3
(Date:8/3/2015)... -- Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" or the ... HZNP ) ("Horizon") announcement that it intends to request ... record date to determine the shareholders eligible to request ... will review the request when it is received. Provided ... information required under Depomed,s bylaws, the Depomed Board will, ...
(Date:8/3/2015)... 3, 2015 Cooperative ... military surgical research and top-tier universities for ... to severe wound treatments for critical-care patients ... medicine and tissue-engineered skin substitute advancements.  Biotech ... in focus are Amarantus Bioscience Holdings, Inc. ...
(Date:8/3/2015)... SINGAPORE , Aug. 3, 2015 ... Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a ... today announced financial results for its first fiscal ... Quarter Highlights and Recent Developments: ... progress in improving its cost structure, driven by ...
Breaking Medicine Technology:Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6
Cached News: